A controlled release Febuxostat composition and a preparation method therefor. The controlled release Febuxostat composition comprises a fast release Febuxostat component and a floating Febuxostat component, and therefore can effectively reduce the peak concentration of the drug in plasma, prolong the effective drug action time, reduce side effects, and improve the compliance of patients.